Figure 3
The geographic prevalence of total and clinically relevant DAA resistance associated variants.
Oceania was not assessed due to the low number of available samples (four sequences). *p < 0.05.
Figure 3 | Scientific Reports
The geographic prevalence of total and clinically relevant DAA resistance associated variants.
Oceania was not assessed due to the low number of available samples (four sequences). *p < 0.05.
